4//SEC Filing
D'Silva Andrew J. 4
Accession 0001628280-25-044426
CIK 0001448431other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 11:26 AM ET
Size
7.5 KB
Accession
0001628280-25-044426
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
D'Silva Andrew J.
Chief Business Officer
Transactions
- Award
Common Stock
2025-08-21+10,417→ 47,514 total - Award
Stock Option
2025-08-21+23,437→ 23,437 totalExercise: $16.14Exp: 2030-08-21→ Common Stock (23,437 underlying)
Footnotes (2)
- [F1]Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date.
- [F2]The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0002083717
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 11:26 AM ET
- Size
- 7.5 KB